<DOC>
	<DOC>NCT01714063</DOC>
	<brief_summary>The primary objective of this study is to determine ex vivo the amount of fluticasone deposited onto a filter (delivered dose) interposed between the OptiChamber Diamond VHC mouthpiece and the subject's mouth during coordinated and uncoordinated actuation/inhalation maneuver.</brief_summary>
	<brief_title>Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use</brief_title>
	<detailed_description />
	<criteria>â€¢ Asthmatic children between the ages of 5 and 8 followed at Arkansas Children's Hospital. The subjects must be available to complete the study. The subject's parent(s) and/or the subject's legal guardian must provide written informed consent to participate in the study. The subject must provide assent when older than 7 years old. The subjects should have used a pMDI VHC previously and be able to use a VHC with mouthpiece. The subjects should have been prescribed fluticasone or another inhaled corticosteroid delivered via a pMDI VHC combination. Clinically stable asthma. Cooperative, i.e., subject should be able to follow and understand instructions. The subject must satisfy the study investigator about his/her fitness to participate in the study. Clinically significant respiratory disease in the previous 4 weeks. Participation in any other clinical trial in the previous 4 weeks. Lack of cooperation, subject cannot follow and understand instructions.</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>pediatric</keyword>
	<keyword>asthma</keyword>
	<keyword>metered dose inhaler</keyword>
	<keyword>valved holding chamber</keyword>
	<keyword>pMDI</keyword>
	<keyword>VHC</keyword>
</DOC>